Skip to content
DraconiticResearch
Search Sources API
203,203 studies31 sourcesUpdated 2 min ago
Peer-reviewedCC BY-NC-SASaudi journal of anaesthesia

A comparative study between hyperbaric prilocaine 2% versus hyperbaric bupivacaine 0.5% for intrathecal anesthesia in cesarean section.

  1. 1Department of Anesthesia, Surgical ICU and Pain Management, Faculty of Medicine, Sohag University, Sohag, Egypt.
  2. 2Department of Anesthesia, Faculty of Medicine, Sohag University, Sohag, Egypt.

Abstract

Background

Bupivacaine has a variable block duration, while prilocaine provides a shorter, more predictable block but is less used in obstetrics. The goal is to compare the onset and duration of block induced by hyperbaric prilocaine 2% and hyperbaric bupivacaine 0.5% in intrathecal anesthesia for women undergoing elective cesarean sections (CS).Methods

A prospective randomized and double-blind clinical trial included 144 individuals with uncomplicated pregnancies belonging to the American Society of Anesthesiologists physical status I or II. Patients were divided into two equal groups randomly: prilocaine group (Group A): received 60 mg hyperbaric prilocaine 2% (3 ml) intrathecally, and bupivacaine group (Group B): received 12.5 mg hyperbaric bupivacaine 0.5% (2.5 ml) intrathecally and 0.5 ml of normal saline. As 60 mg hyperbaric prilocaine 2% is equipotent to 12.5 mg of hyperbaric bupivacaine 0.5%. Onset time and duration of sensory and motor block recorded.Results

Mean arterial blood pressure was higher in Group A than in Group B at 5, 10, 15, and 20 min (P < 0.001), with no differences at baseline or 25-45 min. Intraoperative heart rate was substantially higher in Group B at 5, 10, 15, and 20 min, with comparable values at other time points. Visual analog scale (VAS) scores were higher in Group A at 1 h (P < 0.001) but substantially lower at 2 and 3 h (P < 0.001); VAS scores at 4 h were similar between groups.Conclusion

Hyperbaric prilocaine 2% provides faster onset, shorter sensory and motor block duration, more stable hemodynamics and less maternal hypotension than hyperbaric bupivacaine 0.5% in CS, with similar neonatal outcomes and side effects.

Related

  1. Hyperbaric oxygen therapy as a potential treatment for MDD: a narrative review
    Yun Chen Pang, Peter Giacobbe, Fahad Alam
    Frontiers in medicinePeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Complication of hyperbaric oxygen therapy.
    Ke Liu, Lei Wang, Lili Liang +1
    Journal of the American College of Emergency Physicians openPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  3. Changes in patients’ quality of life during hyperbaric oxygen therapy: a repeated-measures pre-post study
    Zahra Farsi, Reza Momen, Hengameh Habibi
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Endocrinology & metabolismCrossref
  4. Hyperbaric oxygen therapy for cervical spinal cord injury
    Sohail R. Daulat, Matthew W. Scarsbrook, Nikhil Dholaria +4
    Radiology case reportsPeer-reviewedCC BY-NC-NDFull textGeneral medicineEurope PMC
  5. Effects of Piracetam and Hyperbaric Oxygen on Histopathological and Circulating Biochemical Responses Following Sciatic Nerve Crush Injury in Rats
    Umut Caner Canoğlu, Ilknur Suidiye Yorulmaz, Mehmet Gamsızkan +4
    Medicina (Kaunas, Lithuania)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
BibTeX
@article{hammam2026comparative,
  title = {{A comparative study between hyperbaric prilocaine 2% versus hyperbaric bupivacaine 0.5% for intrathecal anesthesia in cesarean section.}},
  author = {Elhadad Ali Mousa Hammam and Mostafa Mohamed Abd El Jaber Ahmed and Hala Mahmoud Hashim El Khaiat and Khaled Abdelfattah Mohamed Abdelfattah},
  journal = {Saudi journal of anaesthesia},
  year = {2026},
  month = oct,
  doi = {10.4103/sja.sja_360_26},
  url = {https://europepmc.org/article/MED/42960029},
  note = {CC BY-NC-SA},
}
RIS
TY  - JOUR
TI  - A comparative study between hyperbaric prilocaine 2% versus hyperbaric bupivacaine 0.5% for intrathecal anesthesia in cesarean section.
AU  - Elhadad Ali Mousa Hammam
AU  - Mostafa Mohamed Abd El Jaber Ahmed
AU  - Hala Mahmoud Hashim El Khaiat
AU  - Khaled Abdelfattah Mohamed Abdelfattah
PY  - 2026
DA  - 2026/10/01
JO  - Saudi journal of anaesthesia
DO  - 10.4103/sja.sja_360_26
UR  - https://europepmc.org/article/MED/42960029
AB  - Background  Bupivacaine has a variable block duration, while prilocaine provides a shorter, more predictable block but is less used in obstetrics. The goal is to compare the onset and duration of block induced by hyperbaric prilocaine 2% and hyperbaric bupivacaine 0.5% in intrathecal anesthesia for women undergoing elective cesarean sections (CS).Methods  A prospective randomized and double-blind clinical trial included 144 individuals with uncomplicated pregnancies belonging to the American Society of Anesthesiologists physical status I or II. Patients were divided into two equal groups randomly: prilocaine group (Group A): received 60 mg hyperbaric prilocaine 2% (3 ml) intrathecally, and bupivacaine group (Group B): received 12.5 mg hyperbaric bupivacaine 0.5% (2.5 ml) intrathecally and 0.5 ml of normal saline. As 60 mg hyperbaric prilocaine 2% is equipotent to 12.5 mg of hyperbaric bupivacaine 0.5%. Onset time and duration of sensory and motor block recorded.Results  Mean arterial blood pressure was higher in Group A than in Group B at 5, 10, 15, and 20 min (P < 0.001), with no differences at baseline or 25-45 min. Intraoperative heart rate was substantially higher in Group B at 5, 10, 15, and 20 min, with comparable values at other time points. Visual analog scale (VAS) scores were higher in Group A at 1 h (P < 0.001) but substantially lower at 2 and 3 h (P < 0.001); VAS scores at 4 h were similar between groups.Conclusion  Hyperbaric prilocaine 2% provides faster onset, shorter sensory and motor block duration, more stable hemodynamics and less maternal hypotension than hyperbaric bupivacaine 0.5% in CS, with similar neonatal outcomes and side effects.
SN  - 1658-354X
SN  - 0975-3125
ER  -